 Anthony Saviola
Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crotalid Venoms | 14 | 2025 | 40 | 4.620 |
Why?
| | Crotalus | 14 | 2025 | 27 | 3.990 |
Why?
| | Snake Venoms | 11 | 2024 | 21 | 2.340 |
Why?
| | Proteomics | 17 | 2025 | 1010 | 2.140 |
Why?
| | Proteome | 7 | 2025 | 431 | 1.130 |
Why?
| | Disintegrins | 2 | 2016 | 5 | 1.020 |
Why?
| | Colubridae | 3 | 2021 | 8 | 0.880 |
Why?
| | Head and Neck Neoplasms | 5 | 2024 | 534 | 0.780 |
Why?
| | Antivenins | 4 | 2025 | 59 | 0.760 |
Why?
| | Neglected Diseases | 1 | 2020 | 4 | 0.680 |
Why?
| | Animals | 43 | 2025 | 34600 | 0.620 |
Why?
| | Metalloproteases | 4 | 2024 | 43 | 0.570 |
Why?
| | Cell Adhesion | 2 | 2016 | 445 | 0.570 |
Why?
| | L-Amino Acid Oxidase | 4 | 2019 | 4 | 0.560 |
Why?
| | Mass Spectrometry | 5 | 2023 | 660 | 0.550 |
Why?
| | Predatory Behavior | 2 | 2016 | 43 | 0.540 |
Why?
| | Elapid Venoms | 2 | 2025 | 17 | 0.470 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 70 | 0.460 |
Why?
| | Biological Evolution | 2 | 2017 | 426 | 0.440 |
Why?
| | Extracellular Matrix | 6 | 2025 | 498 | 0.380 |
Why?
| | Mice | 17 | 2025 | 16644 | 0.350 |
Why?
| | Phospholipases A2 | 5 | 2025 | 79 | 0.330 |
Why?
| | Melanoma | 1 | 2016 | 752 | 0.310 |
Why?
| | Tumor Microenvironment | 4 | 2025 | 622 | 0.300 |
Why?
| | Transcriptome | 2 | 2025 | 883 | 0.280 |
Why?
| | Viper Venoms | 2 | 2018 | 9 | 0.280 |
Why?
| | Fibrosis | 3 | 2024 | 522 | 0.270 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 2019 | 323 | 0.270 |
Why?
| | Disease Models, Animal | 3 | 2024 | 3953 | 0.250 |
Why?
| | Toxins, Biological | 2 | 2023 | 11 | 0.250 |
Why?
| | Extracellular Matrix Proteins | 2 | 2024 | 141 | 0.240 |
Why?
| | Coral Snakes | 1 | 2025 | 3 | 0.240 |
Why?
| | Mexico | 3 | 2025 | 190 | 0.240 |
Why?
| | Protein Phosphatase 1 | 1 | 2025 | 33 | 0.240 |
Why?
| | Interleukin-2 | 2 | 2023 | 431 | 0.240 |
Why?
| | Biomimetics | 1 | 2025 | 40 | 0.240 |
Why?
| | Transcription Termination, Genetic | 1 | 2025 | 19 | 0.240 |
Why?
| | Dystrophin-Associated Proteins | 1 | 2024 | 6 | 0.240 |
Why?
| | Mammary Glands, Human | 1 | 2025 | 64 | 0.230 |
Why?
| | Dystrophin | 1 | 2024 | 34 | 0.230 |
Why?
| | Prodrugs | 1 | 2025 | 45 | 0.230 |
Why?
| | Receptor, EphB4 | 1 | 2024 | 36 | 0.230 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 1 | 2024 | 13 | 0.230 |
Why?
| | Ephrin-B2 | 1 | 2024 | 50 | 0.230 |
Why?
| | Biomimetic Materials | 1 | 2025 | 72 | 0.230 |
Why?
| | Indoles | 2 | 2025 | 372 | 0.230 |
Why?
| | Keto Acids | 1 | 2024 | 13 | 0.230 |
Why?
| | Printing, Three-Dimensional | 1 | 2025 | 86 | 0.230 |
Why?
| | PPAR alpha | 1 | 2024 | 59 | 0.220 |
Why?
| | Oleic Acid | 1 | 2024 | 39 | 0.220 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2024 | 39 | 0.220 |
Why?
| | Lactation | 1 | 2025 | 170 | 0.220 |
Why?
| | Interleukin-7 | 1 | 2024 | 59 | 0.220 |
Why?
| | Hydroxamic Acids | 1 | 2024 | 88 | 0.220 |
Why?
| | Herpesvirus 3, Human | 2 | 2024 | 330 | 0.220 |
Why?
| | Acetates | 1 | 2024 | 97 | 0.220 |
Why?
| | Milk, Human | 1 | 2025 | 148 | 0.220 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2025 | 266 | 0.210 |
Why?
| | Lipid Droplets | 1 | 2023 | 22 | 0.210 |
Why?
| | Birth Injuries | 1 | 2023 | 10 | 0.210 |
Why?
| | Lethal Dose 50 | 2 | 2025 | 15 | 0.210 |
Why?
| | Phenotype | 6 | 2023 | 3058 | 0.210 |
Why?
| | Snake Bites | 1 | 2024 | 56 | 0.210 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3184 | 0.210 |
Why?
| | Necrosis | 1 | 2024 | 231 | 0.210 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 159 | 0.210 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2329 | 0.210 |
Why?
| | RNA Precursors | 1 | 2024 | 147 | 0.210 |
Why?
| | Protein Isoforms | 1 | 2024 | 379 | 0.210 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 45 | 0.210 |
Why?
| | Collagen Type I | 1 | 2023 | 118 | 0.210 |
Why?
| | Tissue Scaffolds | 1 | 2025 | 199 | 0.200 |
Why?
| | Vascular Remodeling | 1 | 2024 | 181 | 0.200 |
Why?
| | RNA Splicing | 1 | 2024 | 262 | 0.200 |
Why?
| | Peptide Hydrolases | 1 | 2023 | 106 | 0.200 |
Why?
| | Herpes Zoster | 2 | 2024 | 317 | 0.200 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 128 | 0.200 |
Why?
| | Gene Expression | 2 | 2025 | 1462 | 0.190 |
Why?
| | Ventricular Remodeling | 1 | 2024 | 258 | 0.190 |
Why?
| | RNA Polymerase II | 1 | 2025 | 317 | 0.190 |
Why?
| | Myocardium | 2 | 2024 | 973 | 0.190 |
Why?
| | Humans | 30 | 2025 | 129116 | 0.190 |
Why?
| | Progesterone | 1 | 2023 | 244 | 0.190 |
Why?
| | Microglia | 1 | 2024 | 228 | 0.190 |
Why?
| | Peptides | 3 | 2023 | 911 | 0.190 |
Why?
| | Thrombosis | 2 | 2023 | 323 | 0.190 |
Why?
| | MCF-7 Cells | 3 | 2018 | 115 | 0.190 |
Why?
| | RNA-Binding Proteins | 1 | 2025 | 388 | 0.190 |
Why?
| | Virulence Factors | 1 | 2022 | 153 | 0.180 |
Why?
| | Reactive Oxygen Species | 3 | 2022 | 579 | 0.170 |
Why?
| | Nuclear Proteins | 1 | 2025 | 660 | 0.170 |
Why?
| | Evolution, Molecular | 1 | 2024 | 467 | 0.170 |
Why?
| | Semen | 1 | 2020 | 19 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 1 | 2024 | 525 | 0.170 |
Why?
| | Drug Discovery | 1 | 2021 | 130 | 0.170 |
Why?
| | Cardiomyopathies | 1 | 2023 | 337 | 0.160 |
Why?
| | Trimeresurus | 1 | 2019 | 1 | 0.160 |
Why?
| | Mice, Knockout | 2 | 2024 | 2765 | 0.160 |
Why?
| | Chromatin | 1 | 2023 | 478 | 0.160 |
Why?
| | Serine Proteases | 1 | 2019 | 20 | 0.160 |
Why?
| | Fibrinolytic Agents | 1 | 2021 | 249 | 0.160 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2019 | 46 | 0.160 |
Why?
| | Epithelial Cells | 1 | 2025 | 1036 | 0.160 |
Why?
| | Pancreatic Neoplasms | 2 | 2025 | 878 | 0.160 |
Why?
| | Gene Expression Regulation | 2 | 2025 | 2508 | 0.150 |
Why?
| | Reptilian Proteins | 1 | 2018 | 3 | 0.150 |
Why?
| | Hydrogels | 2 | 2023 | 636 | 0.150 |
Why?
| | Metabolomics | 1 | 2023 | 599 | 0.150 |
Why?
| | Proteins | 2 | 2023 | 936 | 0.150 |
Why?
| | Mitochondria | 1 | 2024 | 854 | 0.150 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 136 | 0.150 |
Why?
| | Alzheimer Disease | 1 | 2024 | 518 | 0.150 |
Why?
| | Apoptosis | 2 | 2018 | 2438 | 0.150 |
Why?
| | Gryllidae | 1 | 2017 | 1 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2024 | 847 | 0.140 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1423 | 0.140 |
Why?
| | Hypoxia | 1 | 2024 | 1035 | 0.140 |
Why?
| | Southwestern United States | 1 | 2017 | 91 | 0.140 |
Why?
| | Lizards | 1 | 2017 | 34 | 0.140 |
Why?
| | Myocardial Infarction | 1 | 2024 | 1014 | 0.140 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 375 | 0.130 |
Why?
| | RNA | 1 | 2023 | 883 | 0.130 |
Why?
| | Adenylyl Cyclases | 1 | 2016 | 82 | 0.130 |
Why?
| | Integrin alphaVbeta3 | 1 | 2016 | 19 | 0.130 |
Why?
| | Cattle | 3 | 2024 | 962 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1689 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 451 | 0.130 |
Why?
| | Bacteria | 1 | 2022 | 811 | 0.130 |
Why?
| | Vitronectin | 1 | 2015 | 5 | 0.120 |
Why?
| | Neutralization Tests | 2 | 2025 | 73 | 0.120 |
Why?
| | DNA, Complementary | 1 | 2015 | 267 | 0.120 |
Why?
| | Fibronectins | 1 | 2015 | 120 | 0.120 |
Why?
| | Phylogeny | 3 | 2025 | 846 | 0.110 |
Why?
| | Stroke | 1 | 2023 | 1067 | 0.110 |
Why?
| | Geography | 1 | 2015 | 186 | 0.110 |
Why?
| | Neoplasms | 2 | 2021 | 2475 | 0.110 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2016 | 325 | 0.110 |
Why?
| | Tumor Suppressor Proteins | 1 | 2016 | 313 | 0.110 |
Why?
| | Antineoplastic Agents | 2 | 2025 | 2060 | 0.110 |
Why?
| | Hypertension, Pulmonary | 1 | 2024 | 1741 | 0.110 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2015 | 475 | 0.110 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2023 | 76 | 0.100 |
Why?
| | Chromatography, Gel | 1 | 2013 | 127 | 0.100 |
Why?
| | Molecular Weight | 1 | 2013 | 331 | 0.100 |
Why?
| | Zinc | 1 | 2015 | 293 | 0.090 |
Why?
| | Female | 9 | 2025 | 68510 | 0.090 |
Why?
| | Cell Movement | 1 | 2016 | 939 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 269 | 0.090 |
Why?
| | Immunotherapy | 2 | 2025 | 588 | 0.080 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 466 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2041 | 0.080 |
Why?
| | Heart Failure | 1 | 2022 | 2158 | 0.080 |
Why?
| | Protein Binding | 2 | 2025 | 2106 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2016 | 2347 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2819 | 0.070 |
Why?
| | Bacterial Proteins | 2 | 2025 | 826 | 0.070 |
Why?
| | Male | 5 | 2024 | 63194 | 0.070 |
Why?
| | Exocrine Glands | 1 | 2025 | 5 | 0.060 |
Why?
| | Salivary Glands | 1 | 2025 | 29 | 0.060 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2025 | 15 | 0.060 |
Why?
| | Drug Liberation | 1 | 2025 | 29 | 0.060 |
Why?
| | Colorado | 1 | 2015 | 4394 | 0.060 |
Why?
| | Naja | 1 | 2024 | 1 | 0.060 |
Why?
| | Elapidae | 1 | 2024 | 5 | 0.060 |
Why?
| | RNA Splice Sites | 1 | 2024 | 45 | 0.060 |
Why?
| | Acute-Phase Proteins | 1 | 2024 | 67 | 0.060 |
Why?
| | Serpins | 1 | 2024 | 31 | 0.060 |
Why?
| | Varicella Zoster Virus Infection | 1 | 2024 | 25 | 0.060 |
Why?
| | Drug Repositioning | 1 | 2024 | 25 | 0.060 |
Why?
| | Fenofibrate | 1 | 2024 | 31 | 0.060 |
Why?
| | Saccharomycetales | 1 | 2024 | 26 | 0.060 |
Why?
| | Virus Activation | 1 | 2024 | 81 | 0.060 |
Why?
| | Acrylamides | 1 | 2024 | 58 | 0.050 |
Why?
| | Corpus Luteum | 1 | 2023 | 20 | 0.050 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2024 | 94 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 110 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 93 | 0.050 |
Why?
| | Species Specificity | 1 | 2025 | 570 | 0.050 |
Why?
| | Trypsin | 1 | 2023 | 74 | 0.050 |
Why?
| | Pelvic Floor | 1 | 2023 | 23 | 0.050 |
Why?
| | Snakes | 1 | 2023 | 20 | 0.050 |
Why?
| | HeLa Cells | 1 | 2025 | 607 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2023 | 25 | 0.050 |
Why?
| | Nucleocapsid | 1 | 2023 | 18 | 0.050 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 20 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 252 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2015 | 2150 | 0.050 |
Why?
| | Cyclophilins | 1 | 2023 | 35 | 0.050 |
Why?
| | Aminophenols | 1 | 2025 | 146 | 0.050 |
Why?
| | Chromosomes | 1 | 2023 | 101 | 0.050 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2023 | 168 | 0.050 |
Why?
| | Parturition | 1 | 2023 | 70 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 199 | 0.050 |
Why?
| | Hormones | 1 | 2023 | 140 | 0.050 |
Why?
| | Steroids | 1 | 2023 | 148 | 0.050 |
Why?
| | Keratinocytes | 1 | 2024 | 243 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2024 | 209 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2025 | 687 | 0.050 |
Why?
| | Serine | 1 | 2023 | 136 | 0.050 |
Why?
| | Proteoglycans | 1 | 2023 | 109 | 0.050 |
Why?
| | Cardiomegaly | 1 | 2023 | 170 | 0.050 |
Why?
| | Workflow | 1 | 2023 | 155 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 69 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2024 | 616 | 0.050 |
Why?
| | Exosomes | 1 | 2023 | 96 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2024 | 281 | 0.050 |
Why?
| | Viral Proteins | 1 | 2024 | 321 | 0.050 |
Why?
| | Sympatry | 1 | 2021 | 13 | 0.050 |
Why?
| | Complement System Proteins | 1 | 2024 | 307 | 0.050 |
Why?
| | Plasma | 1 | 2023 | 201 | 0.050 |
Why?
| | Arginine | 1 | 2023 | 259 | 0.050 |
Why?
| | Fatty Acids | 1 | 2024 | 415 | 0.050 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 227 | 0.050 |
Why?
| | Estrogens | 1 | 2024 | 354 | 0.040 |
Why?
| | Pregnancy | 2 | 2023 | 6375 | 0.040 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2024 | 378 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2024 | 528 | 0.040 |
Why?
| | India | 1 | 2021 | 170 | 0.040 |
Why?
| | Metabolome | 1 | 2023 | 318 | 0.040 |
Why?
| | Phosphorylation | 1 | 2025 | 1687 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5284 | 0.040 |
Why?
| | Signal Transduction | 2 | 2024 | 4838 | 0.040 |
Why?
| | Myocytes, Cardiac | 1 | 2024 | 495 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 429 | 0.040 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2020 | 27 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2021 | 226 | 0.040 |
Why?
| | Swine | 1 | 2022 | 745 | 0.040 |
Why?
| | Electron Transport | 1 | 2020 | 112 | 0.040 |
Why?
| | Islands | 1 | 2019 | 3 | 0.040 |
Why?
| | Indonesia | 1 | 2019 | 21 | 0.040 |
Why?
| | Skin | 1 | 2024 | 719 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2019 | 64 | 0.040 |
Why?
| | Gelatin | 1 | 2019 | 40 | 0.040 |
Why?
| | Pulmonary Artery | 1 | 2024 | 1030 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1403 | 0.040 |
Why?
| | Conserved Sequence | 1 | 2019 | 228 | 0.040 |
Why?
| | Proteolysis | 1 | 2019 | 162 | 0.040 |
Why?
| | Caspase 8 | 1 | 2018 | 48 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2025 | 1192 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2022 | 398 | 0.040 |
Why?
| | Fibrinogen | 1 | 2019 | 158 | 0.040 |
Why?
| | Caspase 9 | 1 | 2018 | 54 | 0.040 |
Why?
| | Guam | 1 | 2017 | 7 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2018 | 67 | 0.040 |
Why?
| | Stem Cells | 1 | 2022 | 579 | 0.040 |
Why?
| | Introduced Species | 1 | 2017 | 36 | 0.040 |
Why?
| | MicroRNAs | 1 | 2024 | 677 | 0.040 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2024 | 1048 | 0.040 |
Why?
| | Heart Ventricles | 1 | 2022 | 768 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2023 | 1109 | 0.030 |
Why?
| | Ultraviolet Rays | 1 | 2020 | 384 | 0.030 |
Why?
| | Anticoagulants | 1 | 2021 | 614 | 0.030 |
Why?
| | Glutathione | 1 | 2018 | 334 | 0.030 |
Why?
| | Caspase 7 | 1 | 2015 | 20 | 0.030 |
Why?
| | Pakistan | 1 | 2015 | 75 | 0.030 |
Why?
| | Rats | 1 | 2023 | 5173 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 799 | 0.030 |
Why?
| | Inflammation | 1 | 2024 | 2668 | 0.030 |
Why?
| | Risk Assessment | 1 | 2023 | 3260 | 0.030 |
Why?
| | Aging | 1 | 2024 | 1771 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2023 | 1640 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1491 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3033 | 0.020 |
Why?
| | Brain | 1 | 2024 | 2628 | 0.020 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 753 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3120 | 0.020 |
Why?
| | Aged | 1 | 2024 | 22083 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 31074 | 0.010 |
Why?
|
|
Saviola's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|